Doptelet 20 mg
As listed in the register: Doptelet 20 mg, Filmtabletten
20 mg ·
- Prescription only
- Blood, clotting and anaemia
- Active substance
- Avatrombopagum
- Used in
- Blood, clotting and anaemia
- Made by
- Swedish Orphan Biovitrum AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Schwere Thrombozytopenie bei Erwachsenen mit chronischer Lebererkrankung, bei denen ein invasiver Eingriff geplant ist; Chronische Immunthrombozytopenie bei Erwachsenen, die unzureichend auf mindestens eine vorherige Behandlung angesprochen haben
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Swedish Orphan Biovitrum AG |
|---|---|
| Active substance | Avatrombopagum |
| Used in | Blood, clotting and anaemia |
| Strength | 20 mg |
| Classification | B02BX08 · Blood, clotting and anaemia |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Doptelet 20 mg, Filmtabletten |
| Packs | 10 Tablette(n) · 15 Tablette(n) · 30 Tablette(n) |
| Zulassungsnummer | 67893 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.